ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...

Medtech giant Abbott is buying New Brighton-based Cardiovascular Systems Inc. for $890 million, expanding its portfolio in treating artery disease. Cardiovascular Systems (CSI) specializes in ...

Abbott will gain an innovative, complementary solution in treating vascular disease through CSI's leading atherectomy system, which prepares vessels for angioplasty or stenting to restore blood flow ...

ABBOTT PARK, Ill., April 27, 2023 /PRNewswire/ -- Abbott (ABT) today announced it has completed the acquisition of Cardiovascular Systems, Inc. (CSI), a medical device company with an innovative ...

ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...

Cardiovascular Systems Inc. (CSI) reported the submission by its partner Innova Vascular Inc. of U.S. FDA premarket notification for thrombectomy devices to treat peripheral vascular disease. Already ...

“During Q4, we achieved strong sequential growth across all business segments with our U.S. peripheral and coronary atherectomy franchises growing 9% and 16% over prior quarter, respectively.

Abbott Laboratories announced it will acquire Cardiovascular Systems, Inc. (CSI) for $890 million Thursday morning. CSI is a medical device company based in St. Paul, Minnesota that manufactures ...

Cardiovascular Systems Inc. (CSI) reported the submission by its partner Innova Vascular Inc. of U.S. FDA premarket notification for thrombectomy devices to treat peripheral vascular disease. Already ...

The proliferation of outpatient and ambulatory surgical centers has further enhanced the accessibility of atherectomy procedures, creating a favorable environment for market expansion. Despite this ...

In adults with peripheral arterial disease, a directional atherectomy system significantly reduced vessel stenosis and plaque burden vs. an orbital atherectomy system, even after drug-coated balloon ...